Literature DB >> 27641938

Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.

S Balakrishnan1, F A Bhat1, P Raja Singh1, S Mukherjee2,3, P Elumalai1, S Das2,3, C R Patra2,3, J Arunakaran4.   

Abstract

OBJECTIVES: Epidermal growth factor plays a critical role in breast malignancies by enhancing cell proliferation, invasion, angiogenesis and metastasis. Epithelial-mesenchymal transition (EMT) is a crucial process by which epithelial cells lose polarity and acquire migratory mesenchymal properties. Gold nanoparticles are an efficient drug delivery vehicle for carrying chemotherapeutic agents to target cancer cells and quercetin is an anti-oxidative flavonoid known with potent anti-malignant cell activity.
MATERIALS AND METHODS: Cell viability was assessed by MTT assay, and protein expression was examined by Western blotting and immunocytochemistry. Cell invasion was monitored using invasion chambers, and cell migration was analysed by scratch wound-healing assay. In vitro and ex vivo angiogenesis studies were performed by capillary-like tube formation assay and chick embryo angiogenesis assay (CEA). 7,12-dimethylbenz(a)anthracene (DMBA) induced mammary carcinoma in Sprague-Dawley rats.
RESULTS: We observed a significant reduction in protein expression of vimentin, N-cadherin, Snail, Slug, Twist, MMP-2, MMP-9, p-EGFR, VEGFR-2, p-PI3K, Akt and p-GSK3β, and enhanced E-cadherin protein expression in response to AuNPs-Qu-5 treatment. AuNPs-Qu-5 inhibited migration and invasion of MCF-7 and MDA-MB-231 cells compared to free quercetin. AuNPs-Qu-5-treated HUVECs had reduced cell viability and capillary-like tube formation. In vitro and in vivo angiogenesis assays showed that AuNPs-Qu-5 suppressed tube and new blood vessel formation. Treatment with AuNPs-Qu-5 impeded tumour growth in DMBA-induced mammary carcinoma in SD rats compared to treatment with free quercetin.
CONCLUSION: Our results suggest that AuNPs-Qu-5 inhibited EMT, angiogenesis and metastasis of the breast cancer cells tested by targeting the EGFR/VEGFR-2 signalling pathway.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27641938      PMCID: PMC6496551          DOI: 10.1111/cpr.12296

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  47 in total

Review 1.  Induction and regulation of epithelial-mesenchymal transitions.

Authors:  B Boyer; A M Vallés; N Edme
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

2.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

Review 3.  Breast cancer metastasis: markers and models.

Authors:  Britta Weigelt; Johannes L Peterse; Laura J van 't Veer
Journal:  Nat Rev Cancer       Date:  2005-08       Impact factor: 60.716

4.  Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro.

Authors:  Fangting Li; Yujing Bai; Min Zhao; Lvzhen Huang; Shanshan Li; Xiaoxin Li; Yi Chen
Journal:  Ophthalmic Res       Date:  2015-02-07       Impact factor: 2.892

Review 5.  Flavonoids: recent advances as anticancer drugs.

Authors:  Hai L Liu; Wen B Jiang; Meng X Xie
Journal:  Recent Pat Anticancer Drug Discov       Date:  2010-06       Impact factor: 4.169

6.  LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.

Authors:  Hui-Wen Lue; Xiaojian Yang; Ruoxiang Wang; Weiping Qian; Roy Z H Xu; Robert Lyles; Adeboye O Osunkoya; Binhua P Zhou; Robert L Vessella; Majd Zayzafoon; Zhi-Ren Liu; Haiyen E Zhau; Leland W K Chung
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

7.  Non-stimulated, agonist-stimulated and store-operated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry.

Authors:  Felicity M Davis; Amelia A Peters; Desma M Grice; Peter J Cabot; Marie-Odile Parat; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.

Authors:  Poyil Pratheeshkumar; Amit Budhraja; Young-Ok Son; Xin Wang; Zhuo Zhang; Songze Ding; Lei Wang; Andrew Hitron; Jeong-Chae Lee; Mei Xu; Gang Chen; Jia Luo; Xianglin Shi
Journal:  PLoS One       Date:  2012-10-18       Impact factor: 3.240

9.  Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer.

Authors:  Jia Chen; Tao Wang; Yang-Chun Zhou; Fei Gao; Zhi-Hong Zhang; Hao Xu; Shou-Lin Wang; Li-Zong Shen
Journal:  J Exp Clin Cancer Res       Date:  2014-05-03

10.  Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells.

Authors:  Ying-Jang Lai; Chen-Jei Tai; Chia-Woei Wang; Chen-Yen Choong; Bao-Hong Lee; Yeu-Ching Shi; Cheng-Jeng Tai
Journal:  Molecules       Date:  2016-04-28       Impact factor: 4.411

View more
  43 in total

1.  Flavonoid-Decorated Nano-gold for Antimicrobial Therapy Against Gram-negative Bacteria Escherichia coli.

Authors:  Suvadra Das; Tanay Pramanik; Megha Jethwa; Partha Roy
Journal:  Appl Biochem Biotechnol       Date:  2021-03-13       Impact factor: 2.926

Review 2.  Nanoparticle-mediated targeted drug delivery for breast cancer treatment.

Authors:  Piumi Y Liyanage; Sajini D Hettiarachchi; Yiqun Zhou; Allal Ouhtit; Elif S Seven; Cagri Y Oztan; Emrah Celik; Roger M Leblanc
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

Review 3.  Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update.

Authors:  Partha Roy; Srija Sur; Suvadra Das; Wong Tin Wui
Journal:  Breast Cancer       Date:  2022-05-16       Impact factor: 3.307

Review 4.  Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.

Authors:  Jianbo Zhou; Li Wang; Cheng Peng; Fu Peng
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

Review 5.  Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance.

Authors:  Rui Li; Zhimin Chen; Zhifei Dai; Yingjie Yu
Journal:  Cancer Biol Med       Date:  2021-03-23       Impact factor: 4.248

6.  Antitumor and Radiosensitizing Effects of Zinc Oxide-Caffeic Acid Nanoparticles against Solid Ehrlich Carcinoma in Female Mice.

Authors:  Hayam M Sayed; Mahmoud M Said; Nadia Y S Morcos; Mona A El Gawish; Amel F M Ismail
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

7.  UBE2J2 promotes hepatocellular carcinoma cell epithelial-mesenchymal transition and invasion in vitro.

Authors:  Shaopeng Chen; Ying Tan; Haihua Deng; Zhifa Shen; Yanhong Liu; Pan Wu; Chunyan Tan; Yuyang Jiang
Journal:  Oncotarget       Date:  2017-05-03

8.  Injectable and thermosensitive TGF-β1-loaded PCEC hydrogel system for in vivo cartilage repair.

Authors:  Tengfei Zhou; Xiaolong Li; Guo Li; Taoran Tian; Shiyu Lin; Sirong Shi; Jinfeng Liao; Xiaoxiao Cai; Yunfeng Lin
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

Review 9.  Cancer chemoprevention through dietary flavonoids: what's limiting?

Authors:  Haneen Amawi; Charles R Ashby; Amit K Tiwari
Journal:  Chin J Cancer       Date:  2017-06-19

Review 10.  Drug delivery approaches for breast cancer.

Authors:  Santosh Kumar Singh; Shriti Singh; James W Lillard; Rajesh Singh
Journal:  Int J Nanomedicine       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.